These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28612243)

  • 1. Increased expression of Bruton's tyrosine kinase in peripheral blood is associated with lupus nephritis.
    Kong W; Deng W; Sun Y; Huang S; Zhang Z; Shi B; Chen W; Tang X; Yao G; Feng X; Sun L
    Clin Rheumatol; 2018 Jan; 37(1):43-49. PubMed ID: 28612243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
    Mina-Osorio P; LaStant J; Keirstead N; Whittard T; Ayala J; Stefanova S; Garrido R; Dimaano N; Hilton H; Giron M; Lau KY; Hang J; Postelnek J; Kim Y; Min S; Patel A; Woods J; Ramanujam M; DeMartino J; Narula S; Xu D
    Arthritis Rheum; 2013 Sep; 65(9):2380-91. PubMed ID: 23754328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
    Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus.
    Chalmers SA; Wen J; Doerner J; Stock A; Cuda CM; Makinde HM; Perlman H; Bosanac T; Webb D; Nabozny G; Fine JS; Klein E; Ramanujam M; Putterman C
    Arthritis Res Ther; 2018 Jan; 20(1):10. PubMed ID: 29370834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HM71224, a selective Bruton's tyrosine kinase inhibitor, attenuates the development of murine lupus.
    Kim YY; Park KT; Jang SY; Lee KH; Byun JY; Suh KH; Lee YM; Kim YH; Hwang KW
    Arthritis Res Ther; 2017 Sep; 19(1):211. PubMed ID: 28950886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFN
    Katewa A; Wang Y; Hackney JA; Huang T; Suto E; Ramamoorthi N; Austin CD; Bremer M; Chen JZ; Crawford JJ; Currie KS; Blomgren P; DeVoss J; DiPaolo JA; Hau J; Johnson A; Lesch J; DeForge LE; Lin Z; Liimatta M; Lubach JW; McVay S; Modrusan Z; Nguyen A; Poon C; Wang J; Liu L; Lee WP; Wong H; Young WB; Townsend MJ; Reif K
    JCI Insight; 2017 Apr; 2(7):e90111. PubMed ID: 28405610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Blockade of Immune Complex-Mediated Glomerulonephritis by Highly Selective Inhibition of Bruton's Tyrosine Kinase.
    Chalmers SA; Doerner J; Bosanac T; Khalil S; Smith D; Harcken C; Dimock J; Der E; Herlitz L; Webb D; Seccareccia E; Feng D; Fine JS; Ramanujam M; Klein E; Putterman C
    Sci Rep; 2016 May; 6():26164. PubMed ID: 27192942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BTK inhibition modulates multiple immune cell populations involved in the pathogenesis of immune mediated nephritis.
    Chalmers SA; Garcia SJ; Webb D; Herlitz L; Fine J; Klein E; Ramanujam M; Putterman C
    Clin Immunol; 2021 Feb; 223():108640. PubMed ID: 33296718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bruton's Tyrosine Kinase, a Component of B Cell Signaling Pathways, Has Multiple Roles in the Pathogenesis of Lupus.
    Satterthwaite AB
    Front Immunol; 2017; 8():1986. PubMed ID: 29403475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Bruton's tyrosine kinase in B cells and malignancies.
    Pal Singh S; Dammeijer F; Hendriks RW
    Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAP-expressing T peripheral helper cells identify systemic lupus erythematosus patients with lupus nephritis.
    Gartshteyn Y; Geraldino-Pardilla L; Khalili L; Bukhari S; Lerrer S; Winchester RJ; Askanase AD; Mor A
    Front Immunol; 2024; 15():1327437. PubMed ID: 38550577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials.
    Rozkiewicz D; Hermanowicz JM; Kwiatkowska I; Krupa A; Pawlak D
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus.
    Hutcheson J; Vanarsa K; Bashmakov A; Grewal S; Sajitharan D; Chang BY; Buggy JJ; Zhou XJ; Du Y; Satterthwaite AB; Mohan C
    Arthritis Res Ther; 2012 Nov; 14(6):R243. PubMed ID: 23136880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of BTK prevents murine lupus and antibody-mediated glomerulonephritis.
    Rankin AL; Seth N; Keegan S; Andreyeva T; Cook TA; Edmonds J; Mathialagan N; Benson MJ; Syed J; Zhan Y; Benoit SE; Miyashiro JS; Wood N; Mohan S; Peeva E; Ramaiah SK; Messing D; Homer BL; Dunussi-Joannopoulos K; Nickerson-Nutter CL; Schnute ME; Douhan J
    J Immunol; 2013 Nov; 191(9):4540-50. PubMed ID: 24068666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin Binding Protein 1 as a Potential Urine Biomarker in Patients with Lupus Nephritis.
    Lee EJ; Kwon OC; Ghang B; Lim DH; Kim DH; Hong S; Lee CK; Yoo B; Kim YG
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excessive activation of the TLR9/TGF-β1/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus.
    Yuan Y; Yang M; Wang K; Sun J; Song L; Diao X; Jiang Z; Cheng G; Wang X
    Arthritis Res Ther; 2017 Mar; 19(1):70. PubMed ID: 28356164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Bruton's Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease.
    Corneth OBJ; Verstappen GMP; Paulissen SMJ; de Bruijn MJW; Rip J; Lukkes M; van Hamburg JP; Lubberts E; Bootsma H; Kroese FGM; Hendriks RW
    Arthritis Rheumatol; 2017 Jun; 69(6):1313-1324. PubMed ID: 28141917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
    Crofford LJ; Nyhoff LE; Sheehan JH; Kendall PL
    Expert Rev Clin Immunol; 2016 Jul; 12(7):763-73. PubMed ID: 26864273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
    Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H
    Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.